General
Preferred name
vildagliptin
Synonyms
Vildagliptin dihydrate ()
LAF237 dihydrate ()
NVP-LAF 237 dihydrate ()
NVP-LAF 237 ()
LAF237 ()
Vildagliptin (LAF-237) ()
Vitagliptin ()
LAF 237 ()
LAF-237 ()
NVP-LAF237 ()
Galvus ()
Vildagliptin-d7 ()
P&D ID
PD009355
CAS
274901-16-5
1133208-42-0
Tags
covalent binder
natural product
drug
available
Approved by
EMA
First approval
2007
Drug Status
investigational
approved
Drug indication
Type-2 diabetes
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor class anti-diabetic drug. (GtoPdb)
Compound Sets
24
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CovalentInDB
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
68
Properties
(calculated by RDKit )
Molecular Weight
303.19
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
5
Aromatic Ring Count
0
cLogP
1.17
TPSA
76.36
Fraction CSP3
0.88
Chiral centers
3.0
Largest ring
6.0
QED
0.82
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Dipeptidyl Peptidase
DPP-4
Ferroptosis
DPP4 inhibitor
DPP
Pathway
Metabolic Enzyme/Protease
Proteases/Proteasome
Apoptosis
Source data